These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 30038041)
1. Lysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model. Raz A; Serrano A; Thaker M; Alston T; Fischetti VA Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038041 [TBL] [Abstract][Full Text] [Related]
2. Lysibodies are IgG Fc fusions with lysin binding domains targeting Raz A; Serrano A; Lawson C; Thaker M; Alston T; Bournazos S; Ravetch JV; Fischetti VA Proc Natl Acad Sci U S A; 2017 May; 114(18):4781-4786. PubMed ID: 28428342 [TBL] [Abstract][Full Text] [Related]
3. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands. Schmelcher M; Powell AM; Becker SC; Camp MJ; Donovan DM Appl Environ Microbiol; 2012 Apr; 78(7):2297-305. PubMed ID: 22286996 [TBL] [Abstract][Full Text] [Related]
4. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. Becker SC; Foster-Frey J; Donovan DM FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148 [TBL] [Abstract][Full Text] [Related]
5. Antistaphylococcal activity of bacteriophage derived chimeric protein P128. Vipra AA; Desai SN; Roy P; Patil R; Raj JM; Narasimhaswamy N; Paul VD; Chikkamadaiah R; Sriram B BMC Microbiol; 2012 Mar; 12():41. PubMed ID: 22439788 [TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. Desbois AP; Gemmell CG; Coote PJ Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480 [TBL] [Abstract][Full Text] [Related]
7. Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic Staphylococcus aureus Infection. Sobieraj AM; Huemer M; Zinsli LV; Meile S; Keller AP; Röhrig C; Eichenseher F; Shen Y; Zinkernagel AS; Loessner MJ; Schmelcher M mBio; 2020 Sep; 11(5):. PubMed ID: 32963004 [No Abstract] [Full Text] [Related]
8. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA). Desbois AP; Lang S; Gemmell CG; Coote PJ J Appl Microbiol; 2010 Feb; 108(2):723-30. PubMed ID: 19709343 [TBL] [Abstract][Full Text] [Related]
9. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin. Placencia FX; Kong L; Weisman LE Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a Bacteriophage-Derived Murein Peptidase for Elimination of Antibiotic-Resistant Staphylococcus aureus. Keary R; Sanz-Gaitero M; van Raaij MJ; O'Mahony J; Fenton M; McAuliffe O; Hill C; Ross RP; Coffey A Curr Protein Pept Sci; 2016; 17(2):183-90. PubMed ID: 26521950 [TBL] [Abstract][Full Text] [Related]
11. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus. Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049 [TBL] [Abstract][Full Text] [Related]
13. The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance. Rodríguez-Rubio L; Martínez B; Rodríguez A; Donovan DM; Götz F; García P PLoS One; 2013; 8(5):e64671. PubMed ID: 23724076 [TBL] [Abstract][Full Text] [Related]
14. MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infections. Roehrig C; Huemer M; Lorgé D; Arn F; Heinrich N; Selvakumar L; Gasser L; Hauswirth P; Chang C-C; Schweizer TA; Eichenseher F; Lehmann S; Zinkernagel AS; Schmelcher M mBio; 2024 Feb; 15(2):e0254023. PubMed ID: 38275913 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic applications of lysostaphin against Staphylococcus aureus. Jayakumar J; Kumar VA; Biswas L; Biswas R J Appl Microbiol; 2021 Sep; 131(3):1072-1082. PubMed ID: 33382154 [TBL] [Abstract][Full Text] [Related]